Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03750292 · ClinicalTrials.gov registry record · NA
Residential Cleaning of Indoor Air to Protect COPD Patients
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03750292: Completed NA study, sponsored by University of Rochester.
NCT03750292 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03750292, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study looks at whether air cleaning devices put in the bedroom and living room of your home could reduce the irritation of your lungs and body that is caused by indoor air pollution. While participating in this study there will be two, 2 month long study segments (Study Period 1 and Study Period 2) where the air filter units, placed in your living room and bedroom windows, will be turned on at your home.
Primary Outcome
The St. Georges Respiratory Questionnaire (SGRQ) is an established, clinically relevant measure of respiratory symptoms, activity level, and impacts on daily life, and is a measure of functional status regularly used and validated in COPD patient populations. The questionnaire is a fixed format 50 item survey completed by the study subject asking questions in three parts: 1) levels of symptomatology including frequency of wheezing, cough, sputum production, and breathlessness, including the dura
Interventions
- DEVICE HEPAirX air filter
- DEVICE control air filter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
What the finished NCT03750292 record still lists
NCT03750292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which HEPAirX air filter is the first listed.
NCT03750292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03750292 about?
NCT03750292 is a clinical study titled "Residential Cleaning of Indoor Air to Protect COPD Patients". This study looks at whether air cleaning devices put in the bedroom and living room of your home could reduce the irritation of your lungs and body that is caused by indoor air pollution. While participating in this study there will be two, 2 month long study segments (Study Period 1 and Study Perio...
What is the current status of trial NCT03750292?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-03-18. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT03750292?
The interventions under investigation include: HEPAirX air filter (DEVICE), control air filter (DEVICE).
Who is sponsoring clinical trial NCT03750292?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03750292's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI